MC
CORZ icon

Maplelane Capital’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Maplelane Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,333
Closed -$209K – 87
2022
Q1 		$209K Buy
+25,333
New +$224K 0.01% 57

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JWM
JGP Wealth Management Bend, Oregon $1.13B AUM 26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Maplelane Capital's CORZ Position: Q2 2022 in Review

Maplelane Capital sold out of Core Scientific, Inc. Common Stock (CORZ) in Q2 2022, closing a stake of 25,333 shares — an estimated $209K sold.

Maplelane Capital first reported a position in CORZ in Q1 2022 and held it in 1 quarter. The position peaked at $209K in Q1 2022. 141 funds tracked by Wall St. Rank hold CORZ as of Q2 2022.

  • Maplelane Capital reported no remaining Core Scientific, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Maplelane Capital sold 25,333 Core Scientific, Inc. Common Stock shares in Q2 2022, an estimated $209K.
  • Maplelane Capital first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Maplelane Capital's Core Scientific, Inc. Common Stock position peaked at $209K in Q1 2022.
  • 141 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q2 2022.

Based on Maplelane Capital's 13F filing for Q2 2022, filed 15 Aug 2022.